250 related articles for article (PubMed ID: 27251562)
1. Organizing pneumonia as the first manifestation of anti-synthetase syndrome.
Priyangika SM; Karunarathna WG; Liyanage I; Gunawardana M; Udumalgala S; Rosa C; Kulatunga A
BMC Res Notes; 2016 Jun; 9():290. PubMed ID: 27251562
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 antibodies--an interesting association.
Kalenian M; Zweiman B
Clin Diagn Lab Immunol; 1997 Mar; 4(2):236-40. PubMed ID: 9067664
[TBL] [Abstract][Full Text] [Related]
3. [The anti-synthetase syndrome].
Bergoin C; Bure M; Tavernier JY; Lamblin C; Maurage CA; Remy-Jardin M; Wallaert B
Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
[TBL] [Abstract][Full Text] [Related]
4. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome.
Yousem SA; Gibson K; Kaminski N; Oddis CV; Ascherman DP
Mod Pathol; 2010 Jun; 23(6):874-80. PubMed ID: 20228783
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies.
Tomonaga M; Sakamoto N; Ishimatsu Y; Kakugawa T; Harada T; Nakashima S; Hara A; Hara S; Horai Y; Kawakami A; Mukae H; Kohno S
Lung; 2015 Feb; 193(1):79-83. PubMed ID: 25394672
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
[TBL] [Abstract][Full Text] [Related]
7. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.
Katsumata Y; Ridgway WM; Oriss T; Gu X; Chin D; Wu Y; Fertig N; Oury T; Vandersteen D; Clemens P; Camacho CJ; Weinberg A; Ascherman DP
J Autoimmun; 2007; 29(2-3):174-86. PubMed ID: 17826948
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
Katsuki Y; Hirakata M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():505-7. PubMed ID: 16111315
[No Abstract] [Full Text] [Related]
9. A woman with anti-histidyl-aminoacyl-tRNA synthetase (Jo-1 antibodies), myositis, hyperglycemia, interstitial lung disease, and morbilliform rashes.
Tsai CY; Tsai YY; Kuo HL; Chou CT
Rheumatol Int; 2005 Mar; 25(2):156-7. PubMed ID: 14770267
[No Abstract] [Full Text] [Related]
10. Polymyositis-dermatomyositis-associated interstitial lung disease.
Douglas WW; Tazelaar HD; Hartman TE; Hartman RP; Decker PA; Schroeder DR; Ryu JH
Am J Respir Crit Care Med; 2001 Oct; 164(7):1182-5. PubMed ID: 11673206
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.
Sasano H; Hagiwara E; Kitamura H; Enomoto Y; Matsuo N; Baba T; Iso S; Okudela K; Iwasawa T; Sato S; Suzuki Y; Takemura T; Ogura T
BMC Pulm Med; 2016 Dec; 16(1):168. PubMed ID: 27903248
[TBL] [Abstract][Full Text] [Related]
12. A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome.
Polosa R; Di Mauro C; Spampinato B; Castelli L; D'Amico G; Edwards CJ; Russo C
J Clin Rheumatol; 2008 Aug; 14(4):219-21. PubMed ID: 18766122
[TBL] [Abstract][Full Text] [Related]
13. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
Häussermann A; Gillissen A; Seidel W
Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
[TBL] [Abstract][Full Text] [Related]
14. Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.
Ascherman DP
Curr Rheumatol Rep; 2015 Sep; 17(9):56. PubMed ID: 26210509
[TBL] [Abstract][Full Text] [Related]
15. A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussion.
Respicio G; Shwaiki W; Abeles M
Conn Med; 2007 Mar; 71(3):151-3. PubMed ID: 17405398
[TBL] [Abstract][Full Text] [Related]
16. Anti-synthetase syndrome presenting as cryptogenic organizing pneumonia.
Haydour Q; Wells MA; McCoy SS; Nelsen E; Escalante P; Matteson EL
Respir Med Case Rep; 2012; 6():13-5. PubMed ID: 26029595
[TBL] [Abstract][Full Text] [Related]
17. [The Jo-1 Syndrome--immunological findings and clinical manifestations].
Seiberlich B; Hunzelmann N; Roers A; Weber M; Schulze-Lohoff E
Med Klin (Munich); 2005 Mar; 100(3):137-42. PubMed ID: 15966441
[TBL] [Abstract][Full Text] [Related]
18. [Polymyositis and Jo-1 syndrome].
Treher E; Niederhoff A; Gellissen U; Schmidt P; Dornberg M; Peter HH
Z Rheumatol; 1993; 52(5):301-6. PubMed ID: 8259722
[TBL] [Abstract][Full Text] [Related]
19. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
Biswas T; Miller FW; Takagaki Y; Plotz PH
J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784
[TBL] [Abstract][Full Text] [Related]
20. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
